West Pharmaceutical Services, Inc. (WST) fair value analysis

S&P 500 · Updated 2026-09-07

West Pharmaceutical Services, Inc. is a manufacturer of packaging and delivery systems for injectable drugs and healthcare products, serving pharmaceutical and healthcare companies globally. The company operates manufacturing facilities and distribution centers across North America, Europe, Asia, and other regions worldwide.

Forward Fair Value verdict

Fairly valued

Based on TickrTrends' weekly Forward Fair Value model, WST is trading at within about 10% of estimated fair value.

WST currently ranks #68 of 113 Healthcare stocks by discount to Forward Fair Value. It has screened as Fairly valued for 3 consecutive weekly runs.

Last price: $339.97
Sector: Healthcare
12-month range: $237.50–$347.94

Derived indicators

Coarse bands from TickrTrends' weekly models; exact figures are part of the full report.

Quality grade: B
Leverage: Low
Margin trend: Stable
Revenue growth: Modest
RSI zone: Neutral
52-week position: The top quarter of its range

What our data shows for WST

Our model validated 17 trailing price-to-earnings windows for WST, built from quarterly earnings records.
Shares are trading in the upper third of their 12-month price range of $237.50–$347.94.
The 14-day relative strength index sits at a neutral 41.

The exact numbers are one step away

The precise Forward Fair Value dollar figure for WST
Exact discount / premium to today's price
The normalized historical P/E behind the estimate, and how many quarters support it
Forward EPS input and fiscal-year basis
Screeners and rankings across the full S&P 500 and Nasdaq universes

See the exact fair value →

How Forward Fair Value works

TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.

Recent WST news

TickrTrends' derived news-sentiment signal for WST is currently leaning positive, computed from recent coverage.

Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity? (finance.yahoo.com, 2026-09-07)
TickrTrends take: West Pharmaceutical Services operates in the Healthcare sector and is currently assessed as fairly valued according to TickrTrends analysis. Given this valuation standing, investors focused on valuation metrics should monitor whether the company's fundamentals shift materially enough to warrant a change from its current fairly valued designation. A fairly valued positioning suggests limited margin of safety at present levels, making execution on operational metrics particularly relevant for those tracking the stock.
Are Wall Street Analysts Predicting West Pharmaceutical Stock Will Climb or Sink? (finance.yahoo.com, 2026-08-27)
TickrTrends take: West Pharmaceutical Services operates in the Healthcare sector and is currently assessed as fairly valued according to TickrTrends analysis. Given that analyst sentiment appears mixed regarding the stock's directional outlook, investors focused on valuation should monitor whether the company's fundamentals shift to justify any movement away from its current fair value position. The disparity between analyst predictions and the fair valuation assessment suggests that near-term price movements may reflect sentiment swings rather than underlying value changes.
Broad-Based Growth Lifted West Pharmaceuticals (WST) in Q2 (finance.yahoo.com, 2026-08-06)
TickrTrends take: West Pharmaceuticals reported broad-based growth across its business segments in Q2, which aligns with its current classification as fairly valued according to TickrTrends analysis. For investors focused on valuation, the key question is whether this growth momentum can sustain at levels that justify the current pricing, or if acceleration beyond market expectations would be needed to shift the assessment. As a healthcare sector company, WST's ability to maintain consistent performance across diverse product lines will likely remain important to monitoring any potential valuation shifts.

What people are saying

Follow the WST conversation: Stocktwits · Reddit · X

TickrTrends weekly updates

2026-09-07 — No material change this week: the verdict, bands and grades all held steady.
2026-09-06 — TickrTrends' derived indicators for WST showed modest shifts this week. The momentum indicator moved from A to none, while the sector discount rank declined from 63 to 68 among Healthcare sector peers. The stock maintains a Fairly valued assessment.
2026-08-31 — TickrTrends initiated weekly Forward Fair Value coverage of this stock.

Frequently asked questions

Is WST stock undervalued?

Based on TickrTrends' Forward Fair Value model (updated 2026-09-07), WST is trading at within about 10% of estimated fair value and screens as fairly valued. The exact fair value and discount are available to subscribers.

What is WST's TickrTrends verdict?

WST's current verdict is Fairly valued, refreshed with every weekly Forward Fair Value run.

How does WST compare to other Healthcare stocks?

WST ranks #68 of 113 Healthcare stocks in TickrTrends' coverage when sorted by discount to Forward Fair Value.

Is WST overbought or oversold?

WST's 14-day RSI is in neutral territory - neither overbought nor oversold.

All Healthcare fair-value coverage →

Head-to-head comparisons

WST vs AZTA · WST vs BAX · WST vs HSIC · WST vs IQV · WST vs MDT